In Vitro Amoebicidal Activity of Imidazolium Salts Against Trophozoites

Imidazolium salt as potent Amoebicide for rapid inactivation of Acanthamoeba spp. trophozoites and cysts

Acanthamoeba spp. are amphizoic protozoa capable of causing several severe diseases in humans and other animals, including granulomatous amoebic encephalitis and Acanthamoeba keratitis (AK). The high resistance of Acanthamoeba genus, especially in its cystic form, to most conventional disinfectants poses a challenge for its management through aseptic practices based on chemical disinfectants. The imidazolium salt (IS) (C16MImCl) demonstrated significant acanthamoebicidal potency against both trophozoites and cysts. However, its biocidal efficacy over a short exposure time, which will shed light on its potential use as a disinfectant, still needs to be studied. Therefore, the acanthamoebicidal effect of IS against trophozoites and cysts of Acanthamoeba polyphaga and Acanthamoeba spp. exposed for 5 and 20 min to concentrations of 250, 125, 62.5, 31.25, 15.62, and 7.81 μg/mL was evaluated in the present study. Exposure of trophozoites of both strains to IS for 20 min significantly reduced trophozoite viability at concentrations ≥62.5 μg/mL. All trophozoites of both strains were inactived 20 min after cessation of IS exposure at concentrations of ≥125 μg/mL for 5 min or ≥15 μg/mL for 20 min. Cyst viability of all strains was significantly reduced after 20 min of exposure to IS at 62.5 and 125 μg/mL, based on the viability exclusion assay with trypan blue dye. However, all cysts exposed to IS at ≥ 125 μg/mL for 20 or 5 min were unable to excyst when incubated for 10 days on non-nutrient agar with Escherichia coli. The acanthamoebicidal efficacy of IS, upon short exposure to concentrations below the cytotoxic value for human keratinocyte cells (IC50 = 171.50 μg/mL), combined with its previously reported bactericidal and fungicidal effects, suggests that IS has the potential to be used in the formulation of multipurpose disinfectants.

A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review

Free-living amoeba (FLA) group includes the potentially pathogenic genera Acanthamoeba, Naegleria, Balamuthia, Sappinia, and Vermamoeba, causative agents of human infections (encephalitis, keratitis, and disseminated diseases). In Brazil, the first report on pathogenic FLA was published in the 70s and showed meningoencephalitis caused by Naegleria spp. FLA studies are emerging, but no literature review is available to investigate this trend in Brazil critically. Thus, the present work aims to integrate and discuss these data. Scopus, PubMed, and Web of Science were searched, retrieving studies from 1974 to 2020. The screening process resulted in 178 papers, which were clustered into core and auxiliary classes and sorted into five categories: wet-bench studies, dry-bench studies, clinical reports, environmental identifications, and literature reviews. The papers dating from the last ten years account for 75% (134/178) of the total publications, indicating the FLA topic has gained Brazilian interest. Moreover, 81% (144/178) address Acanthamoeba-related matter, revealing this genus as the most prevalent in all categories. Brazil’s Southeast, South, and Midwest geographic regions accounted for 96% (171/178) of the publications studied in the present work. To the best of our knowledge, this review is the pioneer in summarising the FLA research history in Brazil.

Applications of medicinal chemistry for drug discovery against Acanthamoeba infections

Acanthamoeba is a genus of free-living amoebae, pervasively found in the environment. Most of its pathogenic species are the causative agent of sight-threatening Acanthamoeba keratitis and fatal granulomatous amoebic encephalitis. Despite the advancements in the field of chemotherapy, treating Acanthamoeba infections is still challenging due to incomplete knowledge of the complicated pathophysiology. In case of infection, the treatment regimen for the patients is often ineffective due to delayed diagnosis, poor specificity, and side-effects. Besides the resistance of Acanthamoeba cysts to most of the drugs, the recurrence of infection further complicates the recovery. Thus, it is necessary to develop an effective treatment which can eradicate these rare, but serious infections. Based on various computational and in vitro studies, it has been established that the synthetic scaffolds such as heterocyclic compounds may act as potential drug leads for the development of antiamoebic drugs. In this review, we report different classes of synthetic compounds especially heterocyclic compounds which have shown promising results against Acanthamoeba. Moreover, the antiamoebic activities of synthetic compounds with their possible mode of actions against Acanthamoeba, have been summarized and discussed in this review.